Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study
Aaron R. Folsom, Pamela L. Lutsey, Nicholas S. Roetker, Wayne D. Rosamond, Mariana Lazo, Susan R. Heckbert, Saonli Basu, Mary Cushman and Elizabeth Selvin
Life Sciences & Biomedicine Public, Environmental & Occupational Health Science & Technology
Purpose: Approximately 10% of the general population has elevated blood concentrations of hepatic enzymes, which are linked to increased coagulation markers. We tested whether elevated hepatic enzymes are associated with increased risk of venous thromboembolism (VIE).
Methods: We followed 12,604 adults with measurements of alanine transaminase, aspartate aminotransferase (AST), and gamma-glutamyl transpeptidase (GGT) prospectively for VTE occurrence.
Results: AST and GGT above the laboratory normal values were associated over two decades of follow-up with increased risk of total (n = 532) and provoked VTE (n = 332), but with not unprovoked VTE (n = 200). In a model adjusted for age, race, sex, hormone replacement, alcohol intake, diabetes, body mass index, estimated glomerular filtration rate, and C-reactive protein, the hazard ratios (HR) (95% confidence interval) for high versus normal AST were 1.46 (1.00-2.11) for total VTE and 1.83 (1.21-2.79) for provoked VTE. For high GGT, the HR were 1.34 (1.06-1.69) for total VTE and 1.43 (1.07-1.91) for provoked VTE. When follow-up was limited to the first 10 years, associations were even stronger (HR approximate to 1.7 for total VFE).
Conclusions: Elevated concentrations of two hepatic enzymes (AST and GGT) in this general middle-aged population are associated with a modestly increased risk of VTE. (C) 2014 Elsevier Inc. All rights reserved.
Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study
Creators
Aaron R. Folsom - University of Minnesota
Pamela L. Lutsey - University of Minnesota
Nicholas S. Roetker - University of Minnesota
Wayne D. Rosamond - University of North Carolina at Chapel Hill
Mariana Lazo - Johns Hopkins University
Susan R. Heckbert - University of Washington
Saonli Basu - University of Minnesota
Mary Cushman - University of Vermont
Elizabeth Selvin - Johns Hopkins University
Publication Details
Annals of epidemiology, v 24(11), pp 817-821
Publisher
Elsevier
Number of pages
5
Grant note
HHSN268201100005C; HHSN268201100006C; HHSN268201100007C; HHSN268201100008C; HHSN268201100009C; HHSN268201100010C; HHSN268201100011C; HHSN268201100012C / Atherosclerosis Risk in Communities (ARIC) Study contracts
R01HL059367 / NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
R01DK089174 / NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
R01 DK089174 / National Institute of Diabetes and Digestive and Kidney Diseases; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
R01 HL059367 / National Heart, Lung, and Blood Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
Resource Type
Journal article
Language
English
Academic Unit
Urban Health Collaborative
Web of Science ID
WOS:000343614700004
Scopus ID
2-s2.0-84908264595
Other Identifier
991020550341804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: